Remove Blood Clot Remove Innovation Remove Technology
article thumbnail

Innovative Aspiration Thrombectomy System by Expanse ICE Receives FDA Clearance for Vessels of the Peripheral Arterial and Venous Systems

DAIC

Blood clots are the third most common vascular disease. Almost one million patients suffer from peripheral blood clots that must be treated each year, and up to 33% of them suffer long-term complications, according to the Center for Disease Control.

article thumbnail

The Texas Heart Institute Collaborates on Multi-institutional DOD Grant to Develop Novel Left Ventricular Assist Device

DAIC

million Department of Defense grant awarded to the Georgia Institute of Technology (Georgia Tech), Yaxin Wang, PhD (seated left), O.H. As an alternative therapeutic option, LVAD heart pumps have been implanted to help patients with end-stage heart failure sustain blood circulation in the body. Through a new four-year, $7.8

article thumbnail

Osso VR Expands Cardiology Training through ACC Collaboration

DAIC

With the integration of Osso VR's immersive technology and the expertise of the ACC, interventionalists will gain access to a state-of-the-art training simulation of the workflow and skills required to successfully perform a left atrial appendage occlusion procedure (LAAO). and globally."

article thumbnail

News from EHRA 2024: International Experts Agree on Standards for Catheter Ablation of Atrial Fibrillation

DAIC

Some patients need computed tomography or transoesophageal echocardiography to exclude the presence of a blood clot in the heart. Blood thinners should not be interrupted before catheter ablation and patients should receive specific instructions from their healthcare provider on continuing their medication.

article thumbnail

Comprehending the Dreadful Impacts of COVID-19 on Cardiovascular Treatments

SoftCath

Do the healthcare clinics have the tools and technologies needed for diagnosing complicated heart conditions? Henceforth, numerous healthcare organizations are stepping forward in bringing a positive change and adopting the latest technologies such as cath lab reporting software, robotic machines for treatments, etc.

article thumbnail

2024’s Mid-Year Review: FDA-Approved Cardiorenal Metabolic Drugs and Devices 

Cardiometabolic Health Congress

February 2024 FDA Approvals: Innovations in Cardiovascular Interventions XACT Carotid Stent System (Approved: 02/07/2024) This approval expands the indications to be used during a Transcarotid Artery Revascularization (TCAR) procedure to prevent future strokes. The label includes a “black box” warning for CV risk due to blood clots.

article thumbnail

Volta Medical Enters into Joint Development Agreement with GE HealthCare to Support Electrophysiologists Treating Atrial Fibrillation

DAIC

Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Volta Medical’s AI solution is designed to assist electrophysiologists in real-time assessment of dispersed electrograms (EGMs).